Healthcare products live inside a trilemma: clinical excellence, patient experience, and operational efficiency. Almost no organization has the resources to lead on all three, and trying usually produces mediocrity across the board. The answer is to pick where you'll win and allocate deliberately: 70 percent of discretionary investment to your primary differentiation area, 20 to your secondary, 10 to your tertiary.
Before any of that, though, some things aren't in the trilemma at all. Patient safety, the clinical evidence your claims and your buyers require, privacy, and regulatory compliance are prerequisites. They get scoped and funded first, to whatever level the obligation demands, and they never compete for share. The 70/20/10 split applies only to what's left after those obligations are met.
That framework comes from building digital health products across multiple organizations. Here's how to apply it.
The healthcare product trilemma
- Clinical excellence: differentiated medical quality, efficacy, and health outcomes, beyond the required standard
- Patient experience: intuitive, engaging, emotionally supportive interactions
- Operational efficiency: sustainable, scalable systems and cost to serve
The central question isn't "how do we do all three well?" It's "where will our limited resources create the most value?"
The 70/20/10 model
The 10 percent allocation isn't neglect. It's the smallest discretionary bet, and it sits on top of the prerequisites, not in place of them. An experience-led product still carries the full safety, evidence, privacy, and compliance load; it just doesn't try to out-innovate everyone clinically at the same time. The model forces you to be honest about where you'll actually stand out.
Choosing your primary focus
Market context
If competitors lead with clinical excellence but ship poor user experiences, differentiate on UX. In a market full of slick but clinically questionable apps, double down on evidence.
Organizational strengths
An organization with deep clinical expertise should lean into medical innovation. One with design talent should lead with experience.
User needs
Some patient populations prioritize outcomes above all. Others value convenience or affordability more. Research yours before deciding.
Three archetypes
1. The clinical innovator (70% clinical excellence)
Leads with breakthrough medical approaches or superior outcomes. Invests in research, clinical validation, and medical expertise. Think advanced diagnostics or AI-powered clinical decision support.
2. The experience leader (70% patient experience)
Differentiates through usability, engagement, and emotional connection. Invests in design and user research. Think consumer health apps and accessible telehealth platforms.
3. The operational optimizer (70% operational efficiency)
Stands out on scalability, cost, or integration. Invests in infrastructure and automation. Think administrative platforms and interoperability solutions.
Building the roadmap
1. Fund the prerequisites first
Safety, required evidence, privacy, and compliance are set by the obligation, not by strategy. Scope them with your clinical, legal, and security leads, fund them fully, and only then split what remains.
2. Sequence by strategic focus
Early initiatives establish differentiation in your primary area. Later phases strengthen the secondary and tertiary.
3. Weight your metrics
Track KPIs across all three pillars, weighted to your strategic focus, so you hold direction without going blind on the other two.
4. Plan for evolution
Once your primary differentiation is established, shift allocation. An experience leader that's won on UX might then invest in clinical validation or scale.
What this looks like in practice
Take a hypothetical chronic pain program whose research says adherence, not protocol, is why existing treatments fail. It meets its safety, evidence, privacy, and compliance obligations in full. Then it puts 70 percent of discretionary investment into patient experience (personalization, engagement, intuitive interfaces), 20 into clinical (evidence-based best practice, no novel protocols), and 10 into operations, knowingly accepting a higher cost to serve for a high-touch model. Whether that bet pays off is an empirical question, and the program should say up front which adherence and outcome measures will decide it.
Strategic focus drives differentiation. Make the deliberate choice about where you'll truly excel, and keep the discipline to hold that focus when the temptation to spread resources evenly shows up. It always shows up.